“C-POST Protocol Update: A Phase 3, Randomized, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo Post Surgery and Radiation Therapy in Patients With High-Risk Cutaneous Squamous Cell Carcinoma”. 2023. SKIN The Journal of Cutaneous Medicine 7 (2): s173. https://doi.org/10.25251/skin.7.supp.173.